The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors

The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors

Human serum albumin (HSA) is a versatile drug carrier with active tumor targeting capacity for an antitumor drug delivery system. Nanoparticle albumin-bound (nab)-technology, such as nab-paclitaxel (Abraxane<sup>®</sup>), has attracted significant interest in drug delivery research. Rece...

Full description

Bibliographic Details
Main Authors:	Ryo Kinoshita, Yu Ishima, Victor T. G. Chuang, Hiroshi Watanabe, Taro Shimizu, Hidenori Ando, Keiichiro Okuhira, Masaki Otagiri, Tatsuhiro Ishida, Toru Maruyama
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Pharmaceutics
Subjects:	human serum albumin dimerization doxorubicin enhanced permeability and retention effect antitumor
Online Access:	https://www.mdpi.com/1999-4923/13/8/1209

Similar Items

Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil<sup>®</sup>) in C26 Tumor-Bearing Immunocompetent Mice
by: Takuma Takayama, et al.
Published: (2020-10-01)

Doxorubicin–Loaded Human Serum Albumin Submicron Particles: Preparation, Characterization and In Vitro Cellular Uptake
by: Saranya Chaiwaree, et al.
Published: (2020-03-01)

The prognostic value of preoperative D-dimer to albumin ratio for overall survival and progression-free survival in colorectal cancer
by: Lishuang Wei, et al.
Published: (2024-02-01)

Acute Kidney Injury Caused by Rhabdomyolysis Is Ameliorated by Serum Albumin-Based Supersulfide Donors through Antioxidative Pathways
by: Mayumi Ikeda-Imafuku, et al.
Published: (2024-01-01)

IFN-γ/Doxorubicin Complex Nanoparticles for Enhancing Therapy in the Context of Human Ovarian Carcinoma
by: Rongyuan Yi, et al.
Published: (2022-07-01)

Diagnostic precision of C-reactive protein to albumin ratio for coagulopathy in patients with COVID-19
by: Oğuz Karabay, et al.
Published: (2022-06-01)

Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
by: Hannah Onafuye, et al.
Published: (2019-08-01)

The D-Dimer/Albumin Ratio Is a Prognostic Marker for Aneurysmal Subarachnoid Hemorrhage
by: Wei Wu, et al.
Published: (2022-12-01)

Effects of human serun albumin in some biological properties of rhodium(II) complexes
by: Espósito Breno P., et al.
Published: (2000-01-01)

Albumin-Based Zn (II)-Quercetin Enzyme Mimic Scavenging ROS for Protection against Cardiotoxicity Induced by Doxorubicin
by: Zehua Shao, et al.
Published: (2022-12-01)

Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice
by: Murugesan K, et al.
Published: (2020-12-01)

A novel S-sulfhydrated human serum albumin preparation suppresses melanin synthesis
by: Mayumi Ikeda, et al.
Published: (2018-04-01)

Usefulness of the d-dimer to albumin ratio for risk assessment in patients with acute variceal bleeding at the emergency department: retrospective observational study
by: Jun Seok Seo, et al.
Published: (2022-07-01)

Long-Acting Thioredoxin Ameliorates Doxorubicin-Induced Cardiomyopathy via Its Anti-Oxidative and Anti-Inflammatory Action
by: Ryota Murata, et al.
Published: (2022-03-01)

Combination Therapy with Doxorubicin-Loaded Reduced Albumin Nanoparticles and Focused Ultrasound in Mouse Breast Cancer Xenografts
by: Daehyun Kim, et al.
Published: (2020-09-01)

Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites
by: Keishi Yamasaki, et al.
Published: (2018-07-01)

Enhanced tumor delivery and antitumor response of doxorubicin loaded albumin nanoparticles formulated based on a Schiff base
by: Li F, et al.
Published: (2016-08-01)

Synthesis and Comparative Study of Nanoparticles Derived from Bovine and Human Serum Albumins
by: Yerkeblan Tazhbayev, et al.
Published: (2020-06-01)

Reversible Dimerization of Human Serum Albumin
by: Alexey Chubarov, et al.
Published: (2020-12-01)

Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin
by: Nayelli Guadalupe Teran-Saavedra, et al.
Published: (2020-11-01)

Doxorubicin Embedded into Nanofibrillated Bacterial Cellulose (NFBC) Produces a Promising Therapeutic Outcome for Peritoneally Metastatic Gastric Cancer in Mice Models via Intraperitoneal Direct Injection
by: Hidenori Ando, et al.
Published: (2021-06-01)

Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer
by: Rama Prajapati, et al.
Published: (2021-06-01)

Vitamin D, Albumin, and D-Dimer as Significant Prognostic Markers in Early Hospitalization in Patients with COVID-19
by: Biljana Popovska Jovičić, et al.
Published: (2023-04-01)

Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin
by: Kenji Tsukigawa, et al.
Published: (2020-12-01)

Salvia officinalis L. extract increase the antitumor effect of Doxorubicin on Ehrlich carcinoma tumor cells
by: Roxana Liana STAN, et al.
Published: (2019-06-01)

Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
by: Wei Chen, et al.
Published: (2020-08-01)

Albumin Binds Doxorubicin via Self–Assembling Dyes as Specific Polymolecular Ligands
by: Anna Jagusiak, et al.
Published: (2022-05-01)

FTY720 Reduces Lipid Accumulation by Upregulating ABCA1 through Liver X Receptor and Sphingosine Kinase 2 Signaling in Macrophages
by: Koki Tachibana, et al.
Published: (2022-11-01)

Sesamol Loaded Albumin Nanoparticles: A Boosted Protective Property in Animal Models of Oxidative Stress
by: Sara Zaher, et al.
Published: (2022-06-01)

D-dimer-albumin ratio (DAR) as a new biomarker for predicting preoperative deep vein thrombosis after geriatric hip fracture patients
by: Wei Yao, et al.
Published: (2023-08-01)

Synthesis and anticancer activity of dimeric podophyllotoxin derivatives
by: Zi C, et al.
Published: (2018-10-01)

Preparation and Characterization of Drug-Delivery System of Chitosan Nanoparticles Containing Doxorubicin for Use in the Treatment of Breast Cancer
by: Sedigheh Vaezifar, et al.
Published: (2019-12-01)

Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy
by: Akmal M. Asrorov, et al.
Published: (2024-06-01)

Prognostic value of total thiol and D-dimer in patients hospitalized with COVID-19
by: Barlak Keti Didem, et al.
Published: (2023-04-01)

Antitumor Effects and Protective Effects Against DOxorubicin-induced Testicular Toxicity of Cultivated Wild Ginseng Extract in the B16/F10 Melanoma-Bearing C57BL/6 Mice
by: Min,Byung-Il, et al.
Published: (2007-02-01)

Partition of fatty acids
by: Richard B. Simpson, et al.
Published: (1974-07-01)

EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy
by: Ye Z, et al.
Published: (2021-03-01)

Contemporary Biomarkers in Pulmonary Embolism Diagnosis: Moving beyond D-Dimers
by: Androniki Gkana, et al.
Published: (2022-09-01)

Biopolymeric Nanogel as a Drug Delivery System for Doxorubicin—Improved Drug Stability and Enhanced Antineoplastic Activity in Skin Cancer Cells
by: Lyubomira Radeva, et al.
Published: (2024-01-01)

Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling
by: Kezheng Peng, et al.
Published: (2023-06-01)